Eliciting social preference weights for Functional Assessment of Cancer Therapy-Lung health states
- PMID: 16277549
- DOI: 10.2165/00019053-200523110-00006
Eliciting social preference weights for Functional Assessment of Cancer Therapy-Lung health states
Abstract
Background: The Functional Assessment of Cancer Therapy-Lung (FACT-L) is a multidimensional measure of quality of life developed for use in the evaluation of interventions in lung cancer.
Objective: To develop a set of utility weights that could be used to convert FACT-L into a single index capable of being used in the economic analysis of clinical trial data.
Method: A core set of FACT-L items were valued in two versions of a 14-page postal survey of over 400 members of the UK general population. Respondents valued hypothetical FACT-L health states using a scale from 0 to 100 (worst to best health state). Respondents also valued their own health using the standard form of the EuroQol EQ-5D. Data were entered into an ordinary least squares regression model.
Results: Item weights estimated in regression analysis yielded values for 10 items from the FACT-L. The summary index based on this selected set of FACT-L items has a maximum value of 0.703 and a minimum value of 0.111.
Conclusion: This study demonstrates a practical method of converting a standard condition-specific measure into a form that has the requisite properties to legitimise its use in cost-utility analysis. The methodology used here is not unique to FACT-L and might be considered appropriate for use in converting similar instruments.
Comment in
-
Eliciting social preference weights for functional assessment of cancer therapy-lung health states.Pharmacoeconomics. 2006;24(3):293-4; author reply 294-6. doi: 10.2165/00019053-200624030-00008. Pharmacoeconomics. 2006. PMID: 16519550 No abstract available.
Similar articles
-
The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale.Pharmacoeconomics. 2007;25(7):591-603. doi: 10.2165/00019053-200725070-00005. Pharmacoeconomics. 2007. PMID: 17610339
-
Comparison of FACT- and EQ-5D-based utility scores in cancer.Value Health. 2012 Mar-Apr;15(2):305-11. doi: 10.1016/j.jval.2011.11.029. Epub 2012 Feb 2. Value Health. 2012. PMID: 22433762
-
Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.J Formos Med Assoc. 2013 Nov;112(11):699-706. doi: 10.1016/j.jfma.2012.12.015. Epub 2013 Feb 12. J Formos Med Assoc. 2013. PMID: 24183199
-
Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom.Value Health. 2011 Jul-Aug;14(5 Suppl 1):S60-4. doi: 10.1016/j.jval.2011.05.007. Value Health. 2011. PMID: 21839901
-
Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.Value Health. 2015 Sep;18(6):846-55. doi: 10.1016/j.jval.2015.07.004. Epub 2015 Aug 24. Value Health. 2015. PMID: 26409613
Cited by
-
The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities.Health Qual Life Outcomes. 2011 Nov 28;9:106. doi: 10.1186/1477-7525-9-106. Health Qual Life Outcomes. 2011. PMID: 22123196 Free PMC article.
-
The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale.Pharmacoeconomics. 2007;25(7):591-603. doi: 10.2165/00019053-200725070-00005. Pharmacoeconomics. 2007. PMID: 17610339
-
Predicting SF-6D utility scores from the Oswestry disability index and numeric rating scales for back and leg pain.Spine (Phila Pa 1976). 2009 Sep 1;34(19):2085-9. doi: 10.1097/BRS.0b013e3181a93ea6. Spine (Phila Pa 1976). 2009. PMID: 19730215 Free PMC article.
-
Quantitative Preferences for Lung Cancer Treatment from the Patients' Perspective: A Systematic Review.Patient. 2020 Oct;13(5):521-536. doi: 10.1007/s40271-020-00434-7. Patient. 2020. PMID: 32686052
-
Eliciting social preference weights for functional assessment of cancer therapy-lung health states.Pharmacoeconomics. 2006;24(3):293-4; author reply 294-6. doi: 10.2165/00019053-200624030-00008. Pharmacoeconomics. 2006. PMID: 16519550 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical